Center for Continuing Education
About The Cleveland Clinic Center for Continuing Education | Call or Email Us | About The Cleveland Clinic
Live Cleveland Clinic CME Courses |  Regularly Scheduled Series (RSS) Registration | Regulary Scheduled Series (RSS) Schedule (pdf)
Disease Management Project Clinical Decisions Cases |  Hepatitis C Management |  Managing Problem Patients with Anti-TNF Inhibitors |  More
Medicine Today Series |  B Cell Series |  Emerging Therapies in Heart Disease Webcast Series |  More
Disease Management Project |  CCJM 1-Minute Consult |  Pharmacotherapy Update Newsletter |  Algorithms for the MICU |  More
Cleveland Clinic Foundation CME Home Contact Us Live CME Courses Online CME Topics Webcasts Online Medical Publications my CME Search Sitemap e-mail Newsletter

How to Obtain AMA PRA Category 1 Credit(s)™

  1. Watch the CME Webcast.
  2. Take the CME posttest.
  3. Login to your account.
  4. Complete the registration / evaluation form.
  5. Print your personalized CME certificate.

 


 

   
 
State of the Art: Biologic Toxicity Epidemiology, Clinical Spectrum, Diagnosis, and Prevention
 
Release Date: January 30, 2008 Expiration Date: January 30, 2009
 

Technical Requirements
(will appear in new window)

 

Accreditation

2.5 AMA PRA Category 1 Credit(s)™.

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity may be submitted for American Osteopathic Association Continuing Medical Education credit in Category 2.

Target Audience

This activity will be directed to rheumatologists, gastroenterologists, dermatologists, pulmonologists, nurse practitioners, physician assistants, and other health care professionals interested in or using biologic therapeutics in autoimmune and inflammatory disorders.

Description

This activity was presented at the Cleveland Clinic Richard J. Fasenmyer Center of Clinical Immunology Biologic Therapies for Autoimmune and Inflammatory Disease States Summit. The reviewed advances in biologic therapies for autoimmune diseases.

Objectives

At the conclusion of this activity, the participant will be able to:

  1. Recognize the most common infections associated with the use of TNF-α inhibitors.
  2. List preventative screening measures to reduce infectious complications associated with the use of TNF-α inhibitors.
  3. Identify risks for opportunistic infections across available agents and classes.
  4. Identify granulomatous infections and treatment with available agents.
  5. Identify data on hepatic toxicity form biologic anti-rheumatic therapies.

Activity Director

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic and Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology

Faculty

Marc D. Cohen, MD
Jack Cush, MD
Jerrold J. Ellner, MD
Thomas File, MD
Richard Rudick, MD

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:

Leonard Calabrese, DO

 
Consulting, Teaching and Speaking
 
Genentech

Teaching and Speaking Abbott; Amgen; Wyeth
 
Marc Cohen, MD



Teaching and Speaking Abbott; BMS; Centocor
  Consulting, Teaching and Speaking:
 
Amgen; Genentech
  Consulting Wyeth
 
Jack Cush, MD



Consulting, Teaching and Speaking
 
Abbott Pharmaceuticals



Consulting Wyeth
  Consulting and Independent Contractor Centocor; UCB
 
Thomas File, MD


Research, Consulting and Speaker’s Bureau Bayer; Binax Incorporated; GlaxoSmithKline; Merck; Ortho-McNeil; Oscient; Pfizer;
Sanofi-Aventis; Schering-Plough; Wyeth
 

The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:

Jerrold J. Ellner, MD
Richard Rudick, MD
Estimated Time of Completion 2 hours 30 minutes

The Cleveland Clinic Foundation Center for Continuing Education acknowledges an educational grant for support of this activity from:

PLATINUM LEVEL

Abbott Amgen Bristol-Myers Squibb
Genentech and Biogen Idec.

Gold Level

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education and UNITECH Communications®.

Contact Information | Privacy Policy | Disclaimer

Copyright © 2008 The Cleveland Clinic Foundation. All Rights Reserved.